Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Cyclically Adjusted FCF per Share: ¥0.28 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600645 Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
66 GF Score
Price ¥18.77
GF Value ¥20.62
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Zhongyuan Union Cell & Gene Engineering Cyclically Adjusted FCF per Share?

Zhongyuan Union Cell & Gene Engineering SHSE:600645 +1.02% 66 Cyclically Adjusted FCF per Share is ¥0.28 as of Mar. 2026. GuruFocus rates SHSE:600645 with a GF Score™ of 66/100 and a GF Value™ of ¥20.62 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Zhongyuan Union Cell & Gene Engineering's adjusted free cash flow per share for the three months ended in Mar. 2026 was ¥0.041. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.28 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Zhongyuan Union Cell & Gene Engineering's average Cyclically Adjusted FCF Growth Rate was 55.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 22.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 18.00% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was -1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Zhongyuan Union Cell & Gene Engineering was 26.00% per year. The lowest was -16.70% per year. And the median was 3.35% per year.

As of today (2026-07-31), Zhongyuan Union Cell & Gene Engineering's current stock price is ¥18.77. Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was ¥0.28. Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted Price-to-FCF of today is 67.04.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhongyuan Union Cell & Gene Engineering was 283.33. The lowest was 59.79. And the median was 124.61.


Zhongyuan Union Cell & Gene Engineering  (SHSE:600645) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=18.77/0.28
=67.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Zhongyuan Union Cell & Gene Engineering was 283.33. The lowest was 59.79. And the median was 124.61.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Zhongyuan Union Cell & Gene Engineering Cyclically Adjusted FCF per Share Related Terms


Zhongyuan Union Cell & Gene Engineering Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhongyuan Union Cell & Gene Engineering Cyclically Adjusted FCF per Share Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.11 0.14 0.17 0.17 0.26

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.19 0.23 0.26 0.28

SHSE:600645 vs VRTX, REGN, RVMD: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted Price-to-FCF falls into.


SHSE:600645
66GF Score
Zhongyuan Union Cell & Gene Engineering Corp Ltd SHSE:600645
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhongyuan Union Cell & Gene Engineering Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Zhongyuan Union Cell & Gene Engineering's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.041/116.3033*116.3033
=0.041

Current CPI (Mar. 2026) = 116.3033.

Zhongyuan Union Cell & Gene Engineering Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.126 101.400 -0.145
201609 -0.111 102.400 -0.126
201612 0.050 102.600 0.057
201703 -0.165 103.200 -0.186
201706 0.007 103.100 0.008
201709 0.207 104.100 0.231
201712 -0.011 104.500 -0.012
201803 -0.047 105.300 -0.052
201806 0.021 104.900 0.023
201809 -0.036 106.600 -0.039
201812 0.067 106.500 0.073
201903 -0.056 107.700 -0.060
201906 0.159 107.700 0.172
201909 0.124 109.800 0.131
201912 0.035 111.200 0.037
202003 -0.041 112.300 -0.042
202006 0.120 110.400 0.126
202009 0.095 111.700 0.099
202012 0.168 111.500 0.175
202103 0.085 112.662 0.088
202106 0.069 111.769 0.072
202109 0.157 112.215 0.163
202112 0.098 113.108 0.101
202203 0.024 114.335 0.024
202206 0.109 114.558 0.111
202209 0.092 115.339 0.093
202212 0.118 115.116 0.119
202303 0.014 115.116 0.014
202306 0.141 114.558 0.143
202309 0.110 115.339 0.111
202312 0.197 114.781 0.200
202403 0.002 115.227 0.002
202406 0.113 114.781 0.114
202409 0.154 115.785 0.155
202412 0.211 114.893 0.214
202503 0.076 115.116 0.077
202506 0.151 114.907 0.153
202509 0.188 115.471 0.189
202512 0.166 115.832 0.167
202603 0.041 116.303 0.041

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of ¥0.28 mean?
Zhongyuan Union Cell & Gene Engineering (SHSE:600645) has a Cyclically Adjusted FCF per Share of ¥0.28 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors.
Is Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted FCF per Share too high?
Zhongyuan Union Cell & Gene Engineering's current Cyclically Adjusted FCF per Share is ¥0.28. Overall, Zhongyuan Union Cell & Gene Engineering has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted FCF per Share compare to VRTX and REGN?
Zhongyuan Union Cell & Gene Engineering's Cyclically Adjusted FCF per Share of ¥0.28 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors. Zhongyuan Union Cell & Gene Engineering's current Cyclically Adjusted FCF per Share is ¥0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongyuan Union Cell & Gene Engineering stock overvalued right now?
Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering (SHSE:600645) is currently considered Fairly Valued. The stock's GF Value™ is ¥20.62, compared to a current price of ¥18.77 — trading 9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is ¥0.28. Zhongyuan Union Cell & Gene Engineering's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Zhongyuan Union Cell & Gene Engineering (SHSE:600645), the current Cyclically Adjusted FCF per Share is ¥0.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Overvalued in 2026?

Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering stock appears to be undervalued. The current stock price of ¥18.77 is trading 9% below its estimated GF Value™ of ¥20.62. GuruFocus considers Zhongyuan Union Cell & Gene Engineering to be Fairly Valued.

Key valuation signals for SHSE:600645:

  • Cyclically Adjusted FCF per Share: ¥0.28
  • GF Value™: ¥20.62 vs. price of ¥18.77 (9% below fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zhongyuan Union Cell & Gene Engineering Business Description

Address 45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
66GF Score

Get the complete analysis for SHSE:600645

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.77
Price
¥20.62
GF Value